NEW YORK, NY / ACCESSWIRE / August 5, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Livongo Health, Inc. (NASDAQ:LVGO) to Teladoc Health, Inc. is fair to Livongo shareholders. Under the terms of the agreement, each Livongo share will be exchanged for 0.5920x shares of Teladoc plus cash consideration of $11.33 for each Livongo share. On behalf of Livongo shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
If you are a Livongo shareholder and would like to discuss your legal rights and options, please visit Livongo Merger or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].
The investigation concerns whether Livongo and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to (1) obtain the best possible consideration for Livongo shareholders; (2) determine whether Teladoc is underpaying for Livongo; and (3) disclose all material information necessary for Livongo shareholders to adequately assess and value the proposed transaction.
If you are a Livongo shareholder and would like to discuss your legal rights and options, please visit https://halpersadeh.com/actions/livongo-health-inc-stock-merger-teladoc or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
SOURCE: Halper Sadeh LLP